Tuesday, October 30, 2018

Pharmaceutical Industry Pays Price for Alliance With Obama Administration

So the Pharmaceutical Research and Manufacturers of America, or PhRMA, the major industry association, worked closely with the GOP to protect its members from regulation.

They made patients and taxpayers the meal instead. The industry spent lavishly to promote the Obama plan, coordinating with the administration while contributing $150 million in advertising.

In 2015, the Obama administration flouted the industry agreement, taking aim at patent protection for biologics and proposing discounts for Medicare.

So far the pharmaceutical industry has contributed $12 million to candidates in both parties, 60 percent of that to Republicans.

Thus, the GOP should not go out of its way to protect an industry which sold its soul, and the American health care system, for mess of pottage.

As tempting as it is to protect the industry, since price controls and other government regulations create extensive collateral damage, it also is important for businesses that collaborate to pay a high price for their treachery.

In the meantime, no industry which helped the Obama administration nationalize the medical system should escape the consequences of doing so.

https://spectator.org/pharmaceutical-industry-pays-price-for-alliance-with-obama-administration/

No comments: